Navigation Links
Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010
Date:2/24/2011

e and price due to competition.  Net sales for the full year were $31.2 million.
  • Tramadol ER:  Net sales for the fourth quarter 2010 were $6.1 compared to $5.5 million in the prior quarter.  Net sales for the full year were $22.6 million. Par Pharmaceutical remains one of only two suppliers of tramadol ER since its launch in November 2009.

  • Other generic products:  For the fourth quarter 2010, net sales from all other generic products were $68.2 million. When adjusted for certain events, fourth quarter net sales were $57.2 million. This compares to adjusted third quarter net sales of $62.2 million.  

  • Megace® ES:  Net sales were $14.8 million for the fourth quarter compared to $16.8 million in the third quarter.  The decrease was due to a decrease in volume and an increase in returns.  Net sales for the full year were $60.9 million.

  • Nascobal® B12 Nasal Spray:  Net sales were $4.8 million for the three months ended December 31, 2010 compared to $4.9 million in the third quarter.  Net sales for the full year were $17.7 million.

  • Total net revenues for the three months ended December 31, 2010, were $227.0 million compared to $290.3 million from prior year, principally driven by additional competition in metoprolol, meclizine, and clonidine.

    Gross margin for the fourth quarter 2010 increased compared to the prior year due primarily to the launches of omeprazole, diazepam, and hydrocodone polistirex and chlorpheniramine polistirex, as well as increases in other generic products.  These gains were partially offset by lower metroprolol, clonidine and meclizine sales and the impact of U.S. healthcare reform enacted in 2010.4Q 20104Q 2009$%$%Key Par (Generic) Products (1)$   42.7

    31.6%$   45.2

    21.6%All other Par (Generic)36.2

    53.1%27.0

    48.6%Total Par (Generic)$   78.9

    38.8%$
    '/>"/>

    SOURCE Par Pharmaceutical Companies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... FALLS, Idaho , April 20, 2015 /PRNewswire/ ... "Company") is pleased to provide shareholders with the ... Cobalt Products Historically, ... is used to fabricate several models of sealed ... include applications such as radiation therapy, security examination, ...
    (Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
    (Date:4/20/2015)... JERUSALEM , April 20, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... the company will participate in the upcoming Annual GTC ... Discovery & Development Conference, taking place April 27-29, 2015 ... Kidron , Oramed,s Chief Scientific Officer, will present a ...
    Breaking Medicine Technology:International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Oramed to Present at the GTC Diabetes Summit 2Oramed to Present at the GTC Diabetes Summit 3
    ... NEW YORK, May 1, 2012 Researchers funded by The ... for testing patient response to therapies to treat dyskinesia, the ... Parkinson,s disease (PD) drugs. MJFF has made dyskinesia a top ... quality of life. The findings, from a ...
    ... SIOUX FALLS, S.D., May 1, 2012 pharmaCline,s Diabecline® ... 2012 Best New Pharmaceutical Product at the 25th Annual ... of the world,s most well known corporations at the ... Awards Innovation Showcase and Forum.  The subsequent Awards Gala ...
    Cached Medicine Technology:Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale 2Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale 3Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale 4Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product 2Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product 3
    (Date:4/20/2015)... April 20, 2015 The NFL draft season ... of players to add to their rosters, both for their ... In this episode of SCI TV , Vinnie ... acquisition of Greg Hardy given increased attention on off-field conduct ... year after the Ray Rice scandal brought media scrutiny, once ...
    (Date:4/20/2015)... (PRWEB) April 20, 2015 Mutare ... has secured nationally-renowned Gastroenterologist Lawrence Kosinski, MD, MBA, ... , Dr. Kosinski brings a unique combination of ... to the Mutare Health team as ... communication, collaboration, and quality of care in the ...
    (Date:4/20/2015)... The normal response from the doctor used to be, “He ... if the patient sought medical care after the six-hour treatment ... So it’s critical the patient’s loved ones or caregiver ask ... Not every emergency room physician or neurosurgeon has the training ... according to Ronald P. Benitez , neurosurgeon and president ...
    (Date:4/20/2015)... Hills, CA (PRWEB) April 20, 2015 Genuine ... have tried diets and gym memberships in the past. But ... weight loss results can be guaranteed by adhering to ... a bad diet. No matter how many hours one spends ... all efforts to lose weight., But a nutritional mean plan ...
    (Date:4/20/2015)... Montana (PRWEB) April 20, 2015 "It's ... has done for our family. Initially, I really thought ... where it would end. But what I've discovered is ... myself, to be together, support each other and walk ... Kori Keller. "I have learned way more from these ...
    Breaking Medicine News(10 mins):Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3
    ... , NEW YORK, July 28 The National Center on ... C. Tuggle has been elected to its board of directors. , ... , Tuggle is senior vice president of Global Public ... in 1989 and has held a variety of positions in the U.S. ...
    ... FRANKLIN, Mass., July 28 PLC Systems Inc. (OTC Bulletin ... news wire its financial results for the second quarter ended June ... The company plans to host a conference call to discuss those ... , The call may be joined via telephone ...
    ... ANN ARBOR, Mich., July 28 Clear Choice Health Plans, ... Treatment Cost Calculator, an application that enables individuals to accurately ... Cost Calculator also shows consumers how costs vary from one ... Choice is headquartered in Bend, Oregon, where a new state ...
    ... , NASHVILLE, Tenn., July 28 ... that planned cuts to Medicare Advantage reimbursement will benefit organizations ... Illinois Health Plan Analysis , the shift from Medicare ... will likely benefit Blue Cross Blue Shield of Illinois, the ...
    ... , , SYDNEY, July 28 /PRNewswire/ ... company focused on innovative heart assist technologies, announced today that the ... at The Ohio State University Medical Center in Columbus, Ohio have ... , Sunshine Heart,s Medical Director, William Peters MD reported, ...
    ... , , , SANTA ... screening programs to help people assess their risk for diabetes, ... test kits can be distributed at an employer wellness event or shipped ... complete guide to using A1c as part of a corporate ...
    Cached Medicine News:Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 3Health News:Clear Choice Health Plans Selects Thomson Reuters to Deliver Healthcare Cost Information to Members - and Exceed State Transparency Requirements 2Health News:Clear Choice Health Plans Selects Thomson Reuters to Deliver Healthcare Cost Information to Members - and Exceed State Transparency Requirements 3Health News:Medigap Plans in Illinois to Benefit From Medicare Advantage Reimbursement Cuts 2Health News:Sunshine Heart Provides C-Pulse U.S. Clinical Update 2Health News:Sunshine Heart Provides C-Pulse U.S. Clinical Update 3Health News:Sunshine Heart Provides C-Pulse U.S. Clinical Update 4Health News:Diabetes Screening Comes Home with A1c Testing 2
    ... Expandable, Multichannel Pipettor The Equalizer ... productivity with an industry breakthroughequal tip spacings ... a slide rod. This innovation allows the ... vessels with different configurations. Adjustable and ...
    ... Equally Spaced, Expandable, Multichannel Pipettor ... instantly boosts productivity with an industry breakthroughequal ... adjustment of a slide rod. This innovation ... liquids between vessels with different configurations. ...
    ... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
    ... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
    Medicine Products: